000028SZSE
🚨 Material Event

Announcement of Resolutions of the Fifth Extraordinary Meeting of the Tenth Board of Directors of Sinopharm Group Co., Ltd.

✨ AI Summary

Sinopharm Group Co., Ltd. held its fifth extraordinary board meeting, approving capital increase, amendments to articles of association, election of independent director, adjustment of board committee members, and the disposal of 51% equity in Guangzhou Huadu Pharmaceutical Technology Co., Ltd. The meeting also announced the date of the first extraordinary general meeting for 2026.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 000028, 200028

Securities Abbreviation: Sinopharm, Sinopharm B

Announcement No.: 2026-28

Sinopharm Group Co., Ltd.

Announcement of Resolutions of the Fifth Extraordinary Meeting of the Tenth Board of Directors

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

I. Convening of the Board Meeting

The Fifth Extraordinary Meeting of the Tenth Board of Directors of Sinopharm Group Co., Ltd. (hereinafter referred to as the "Company") was notified and materials were sent via email on July 21, 2026. The meeting was held via written voting on July 24, 2026. Nine directors were eligible to attend, and nine directors attended the meeting in person. The Company Secretary attended the meeting. The convening procedures of the meeting comply with the relevant provisions of the "Company Law" and the "Articles of Association."

II. Deliberation of Board Meeting Proposals

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.